F 2 -isoprostanes have been advocated as a specific and reliable marker of oxidative damage (1 ) despite a lack of data on their biological and analytical variation. Concurrent with a longitudinal study of oxidative stress during the menstrual cycle [the BioCycle Study (2 )], we have characterized the components of biological and analytical variation of free plasma F 2 -isoprostanes in the context of the menstrual cycle. We describe several of the key characteristics of F 2 -isoprostanes as a biomarker.
Samples were collected from 9 healthy volunteers who met the major inclusion criteria of being a premenopausal woman 18 -44 years of age and having regular menstrual cycles. Major exclusion criteria included use of hormonal preparations or contraceptive devices, pregnancy, a history of gynecologic abnormalities, recent infectious disease, routine intake of prescription and over-the-counter medications (including vitamin and mineral supplements), and a history of certain chronic diseases or conditions. Fasting blood samples were collected between 0700 and 0830 on days 2, 7, 12, 13, 14, 18, 22, and 27 of a single menstrual cycle. Collection and handling protocols were designed to minimize preanalytical variation. Samples were frozen at Ϫ80°C and then analyzed, in duplicate, as a single set of consecutive samples by GC-MS (1 ) at the Molecular Epidemiology and Biomarker Research Laboratory at the University of Minnesota. Samples were analyzed within 6 months of collection.
The SAS software package (version 9.1.3; SAS Institute) was used for all analyses. We logtransformed F 2 -isoprostane data and used the following nested
, where Y ijk describes the value for the kth replicate (k ϭ 1, 2) on the jth day (j ϭ 1, 2, 3, . . . , 8) for the ith individual (i ϭ 1, 2, 3, . . . , 9), is the grand mean, sub i is the random effect of the ith individual, day j(i) is the random effect of the jth day nested in the ith individual, and e k(ji) is the random effect of the kth replicate nested in the jth day and the ith individual. Proportions of total variation from sources between (sub i ) and within (day j(i) ) individuals and from analytical factors (e k(ji) ) were estimated from the relevant variance components B 2 (4 ) . The high ICC value of 0.97 (95% CI, 0.96 -0.98) ensured that decreases in study power due to analytical factors would necessitate a compensatory increase in sample size of 11%, at most.
The II value of 0.42 suggests that population reference limits for the detection of "abnormal" values are likely to be of limited utility. Use of a CD criterion suggests that a minimum difference of 1.0 ng/L between serial samples might be nonstochastic in nature. Estimation of the individual-specific mean F 2 -isoprostane concentration within 5%, 10%, or 20% of the actual mean value will require 13.8, 3.5, or 0.9 simultaneously assayed samples, respectively.
The number of participants in this study was small; however, studies on biological variation have demonstrated that estimates of intraindividual and interindividual variation are similar regardless of the number of individuals studied (5 ). Our estimates of variation agree with those of other studies that did not span the menstrual cycle and suggest that plasma F 2 -isoprostanes are sufficiently reliable for use as a biomarker of oxidative damage in epidemiologic studies of women. 
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